These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5116171)

  • 1. Treatment of mucocutaneous (American) leishmaniasis with amphotericin B: report of 70 cases.
    Sampaio SA; Castro RM; Dillon NL; Martins JE
    Int J Dermatol; 1971; 10(3):179-81. PubMed ID: 5116171
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of amphotericin B in mucocutaneous leishmaniasis.
    Crofts MA
    J Trop Med Hyg; 1976 May; 79(5):111-3. PubMed ID: 933229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [American leishmaniasis of the skin and mucous membranes and its treatment with amphotericin B (author's transl)].
    Mayer PJ
    MMW Munch Med Wochenschr; 1974 Sep; 116(36):1539-46. PubMed ID: 4215958
    [No Abstract]   [Full Text] [Related]  

  • 4. [South american mucocutaneous Leishmaniasis in the region of the Rio Pachitea (author's transl)].
    Heimgartner E; Heimgartner V
    Dermatologica; 1974; 149(4):248-52. PubMed ID: 4376499
    [No Abstract]   [Full Text] [Related]  

  • 5. Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?
    Amato VS; Tuon FF; Camargo RA; Souza RM; Santos CR; Nicodemo AC
    Am J Trop Med Hyg; 2011 Nov; 85(5):818-9. PubMed ID: 22049033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [South American leishmaniasis in medical practice. Therapeutic problems].
    Heimgartner E; Krebs A
    Schweiz Rundsch Med Prax; 1985 Jul; 74(29):779-83. PubMed ID: 3898301
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC).
    Tuon FF; Santos CR; Cieslinski J; Souza RM; Imamura R; Amato VS
    Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e71. PubMed ID: 30427406
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.
    Cunha MA; Leão AC; de Cassia Soler R; Lindoso JA
    Am J Trop Med Hyg; 2015 Dec; 93(6):1214-8. PubMed ID: 26483120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
    Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P;
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucocutaneous leishmaniasis treated with liposomal amphotericin B.
    Lambertucci JR; Silva LC
    Rev Soc Bras Med Trop; 2008; 41(1):87-8. PubMed ID: 18368279
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amphotericin B in the treatment of the otorhinolaryngological forms of paracoccidioidomycosis and leishmaniasis resistent to sulfas and antimonial agents].
    Albernaz PL; Lanzellotti WP; Ganança MM
    Hospital (Rio J); 1968 Sep; 74(3):913-20. PubMed ID: 5310129
    [No Abstract]   [Full Text] [Related]  

  • 12. [Amphotericin B in the treatment of otorhinolaryngologic forms of paracoccidioidosis and leishmaniasis resistant to sulf as the antimonials].
    Albernaz PL; Lanzellotti WP; Ganança MM
    Hospital (Rio J); 1968 Sep; 74(3):913-20. PubMed ID: 5303774
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis.
    Rodriguez LV; Dedet JP; Paredes V; Mendoza C; Cardenas F
    Mem Inst Oswaldo Cruz; 1995; 90(4):525-8. PubMed ID: 8551959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apropos of a case of mucocutaneous leishmaniasis resistant to antimonials and cured by amphotericin B in Guiana].
    Chalchat P; Colas-Belcour J; Destombes P; Drouhet E; Fromentin H; Martin L; Ravisse P; Silverie J
    Bull Soc Pathol Exot Filiales; 1965; 58(1):73-80. PubMed ID: 5898058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Difficulty of treatment of South American leishmaniasis seen again at a one year interval].
    Pothier MA; Coudert J; Nobrega G; Lima Ndos S
    Bull Soc Pathol Exot Filiales; 1970; 63(4):473-6. PubMed ID: 5537232
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome).
    Amato VS; Nicodemo AC; Amato JG; Boulos M; Neto VA
    J Antimicrob Chemother; 2000 Aug; 46(2):341-2. PubMed ID: 10933674
    [No Abstract]   [Full Text] [Related]  

  • 17. Imported mucocutaneous leishmaniasis in New York City. Report of a patient treated with amphotericin B.
    Singer C; Armstrong D; Jones TC; Spiro RH
    Am J Med; 1975 Sep; 59(3):444-7. PubMed ID: 1163553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients.
    Rocio C; Amato VS; Camargo RA; Tuon FF; Nicodemo AC
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):176-8. PubMed ID: 24535153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of leishmaniasis in children].
    Scappini JF; Harvey W
    Arch Argent Pediatr; 1970 Dec; 68(10):369-70. PubMed ID: 5508182
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with endemic dermatological diseases in the Peruvian wilderness: mucocutaneous leishmaniasis and Brazilian foliaceous pemphigus].
    Heimgartner E; De Heimagartner V
    Med Cutan Ibero Lat Am; 1976; 4(1):1-6. PubMed ID: 135891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.